INTERNATIONAL PATENT: OPTICYTE INC. FILES APPLICATION FOR "DETERMINING BLOOD-OXYGEN LEVEL (SPO2) USING BROADBAND SPECTRA TO REDUCE OR ELIMINATE SKIN-TONE BIAS IN THE DETERMINED SPO2 VALUE AND/OR USING BROADBAND SPECTRA TO DETERMINE PULSE RATE"

GENEVA, May 12 -- OPTICYTE INC. (4000 Mason RoadSuite 300Seattle, Washington 98195) filed a patent application (PCT/US2025/053182) for "DETERMINING BLOOD-OXYGEN LEVEL (SPO2) USING BROADBAND SPECTRA TO REDUCE OR ELIMINATE SKIN-TONE BIAS IN THE DETERMINED SPO2 VALUE, AND/OR USING BROADBAND SPECTRA TO DETERMINE PULSE RATE" on Oct 29, 2025. With publication no. WO/2026/096679, the details related to the patent application was published on May 07, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ARAKAKI, Lorilee S. (4000 Mason RoadSuite 300Seattle, Washington 98195), TRONRUD, Thor J. (1002-1400 Qu...